Oculis Holding Ag
(OCS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OCS | AZN | AMGN | GILD | BMY |
| Company | Oculis Holding Ag | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 28.58 | 202.52 | 366.66 | 153.42 | 60.00 |
| High | 28.81 | 205.19 | 369.50 | 155.73 | 60.93 |
| Low | 28.40 | 202.10 | 365.18 | 150.82 | 59.25 |
| Latest | 28.52 | 203.93 | 366.94 | 152.90 | 60.53 |
| Change | -0.06 | -0.83 | +0.36 | -2.90 | +0.60 |
| % Change | -0.21% | -0.41% | +0.10% | -1.86% | +1.00% |
| Volume | 153,913 | 887,580 | 377,117 | 2,852,565 | 2,735,428 |
| 20-Day Average Volume | 333,664 | 4,522,572 | 3,118,244 | 8,551,308 | 13,142,001 |
| Previous Close | 28.58 | 204.76 | 366.58 | 155.80 | 59.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 27.43 | 188.75 | 351.60 | 140.44 | 56.88 |
| 20-Day Raw Stochastic | 86.16% | 98.92% | 73.79% | 88.97% | 85.30% |
| 20-Day Relative Strength | 66.77 | 65.08 | 61.30 | 69.27 | 66.37 |
| Weighted Alpha | +56.24 | +48.29 | +33.38 | +57.31 | +24.53 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 48% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.89% since 02/05/26 | +9.37% since 02/05/26 | +0.19% since 02/05/26 | +2.62% since 02/05/26 | +2.15% since 02/05/26 |
| Low | 27.30 on 02/10/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 147.07 on 02/10/26 | 59.25 on 02/12/26 |
| High | 29.09 on 02/11/26 | 204.98 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +23.37% since 01/12/26 | +9.31% since 01/12/26 | +13.20% since 01/12/26 | +25.02% since 01/12/26 | +9.02% since 01/12/26 |
| Low | 22.60 on 01/14/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 120.22 on 01/13/26 | 53.54 on 01/21/26 |
| High | 29.36 on 02/02/26 | 204.98 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +51.11% since 11/12/25 | +16.73% since 11/12/25 | +9.58% since 11/12/25 | +24.21% since 11/12/25 | +23.88% since 11/12/25 |
| Low | 18.64 on 12/02/25 | 175.24 on 11/13/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 29.36 on 02/02/26 | 204.98 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +57.62% since 08/12/25 | +35.84% since 08/12/25 | +29.31% since 08/12/25 | +27.71% since 08/12/25 | +30.61% since 08/12/25 |
| Low | 16.00 on 09/02/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 29.36 on 02/02/26 | 204.98 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,496,878 | 317,563,904 | 197,396,352 | 193,297,952 | 122,002,680 |
| Shares Outstanding, K | 52,375 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 780,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -97,430,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 300,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -21,060,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 0.28 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.40 on 11/10/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/10/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 23.88 | 16.69 | 18.07 | 9.90 |